Posters

      Interfacial Dynamics of the Model Pulmonary Surfactant in the Presence of Glycerol/Propylene Glycol Mixtures

      Sosnowski, T. R.; Jabłczyńska, K.; Odziomek, M.; Schlage, W. K.; Kuczaj, A. K.

      Conference date
      Feb 21, 2019
      Conference name

      Society for Research on Nicotine and Tobacco (SRNT) 2019
      Link to more information
      Topic
      Summary

      This communication presents a physicochemically-based analysis of direct interactions between the basic components of e-liquids (i.e., glycerol (GL) and propylene glycol (PG) that form the aerosol in electronic nicotine delivery systems (ENDS)) and the model pulmonary surfactant: MPS (Survanta). Experimental studies were done using dynamic drop tensiometer (PAT-1M, Sinterface, Germany) in simulated conditions of the respiration, i.e., during periodic breathing-like variations of the MPS air/ liquid interface at the physiological temperature. Influence of GL, PG and GL/PG mixtures (20-80%) on the interfacial dynamics of the MPS system was studied at a wide concentration range of these ingredients simulating different doses of inhaled e-cigarette aerosols deposited in the pulmonary region. Estimates of the average e-liquid concentration were calculated based on a deposition model for orally inhaled aerosols. MPS dynamics was assessed on the basis of surface rheological parameters, which quantitatively describe the response of the active air/liquid (pulmonary) interface to the mechanical deformations (expansion and contraction) during breathing. The results show that GL, PG and their mixtures induce evident alterations of the original MPS properties (e.g., a decrease in the surface tension amplitude, surface elasticity and surface viscosity) only at very high concentration levels, which exceed by more than 100-fold the average concentration expected after a typical vaping session. It is also demonstrated that the overall effect of PG is stronger than that of GL. The influence of e-liquid constituents on the pulmonary surfactant is discussed on the basis of their adsorption and desorption at the air/liquid region during oscillatory variations of the interfacial area. Discussed physicochemical phenomena may be related to certain changes in the pulmonary surfactant function in vivo. Therefore, the findings from the presented studies should be included into the safety assessment of inhaled ENDS-vapor, also in case of nicotine-free products.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.